Skip to content

New diagnostic center unveiled by Agilus Diagnostics and Karnataka CDC, located in Kuvempunagar, Mysuru

Medical facility now conveniently located in South Mysuru, providing local residents with essential healthcare services.

New Diagnostic Centre Debuts in Kuvempunagar, Mysuru, Led by Agilus Diagnostics and Karnataka CDC
New Diagnostic Centre Debuts in Kuvempunagar, Mysuru, Led by Agilus Diagnostics and Karnataka CDC

New diagnostic center unveiled by Agilus Diagnostics and Karnataka CDC, located in Kuvempunagar, Mysuru

In the ever-evolving world of healthcare, several significant developments have been announced recently.

The EH News Bureau has published a post highlighting a new low-cost test for sepsis and serious infections, developed by JRBiomedical. While the researchers behind this breakthrough have not been specifically named, the test takes a mere 10 minutes to complete, making it a valuable tool in the fight against life-threatening infections.

Meanwhile, DPIIT has signed an MoU with Pfizer to accelerate the lab-to-market journey of healthcare products. This collaboration aims to expedite the process of bringing innovative healthcare solutions to the market, potentially improving patient care and outcomes.

In other news, ShardaCare Healthcity and Sharda Hospital have appointed Sandeep Dogra as their Group COO. This appointment is expected to bring a fresh perspective and new strategies to the management of these healthcare institutions.

On the policy front, Nathealth, a prominent organisation in the healthcare sector, has welcomed the Prime Minister's announcement on GST reforms. However, the article does not provide any specific updates on the nature of these reforms or Nathealth's stance on the matter.

Additionally, Nathealth has called for a standardized GST rate of 5% for the healthcare sector. This advocacy aims to reduce the financial burden on healthcare providers and improve access to quality healthcare for all.

It's important to note that these developments are independent of each other and do not directly relate to recent news such as the WHO adding rapid-acting insulin analogues and GLP-1 receptor agonists to the Essential Medicines List (EML), or discussions on the role of robotics in kidney-preserving cancer care.

As these developments unfold, it's clear that the healthcare sector continues to innovate and adapt, with the ultimate goal of improving patient care and outcomes.

Read also: